Capelle aan den IJssel, the Netherlands - 7 July 2017 - On the Extraordinary General Meeting of Shareholders held today Sean Fernback and Kees Molenaar have been appointed by the shareholders as members of the Supervisory Board of AND.
End of May AND announced to expand the Supervisory Board to five members and to nominate today Sean Fernback and Kees Molenaar for appointment as new members of the Supervisory Board. On 24 May, Sean and Kees were formally nominated and today the appointments are formalized. They are appointed for a period of four years.
Rob Westerhof, chairman of the AND Supervisory Board: "I am delighted with the announcement of these nominations. Sean Fernback, former CEO of HERE, is a true industry expert and brings a wealth of experience and in-depth knowledge of the mapping, navigation and location spaces. Kees Molenaar has a broad experience in advisory boards and is very familiar with the Dutch corporate governance model. I am certain that they will be of great benefit to the functioning of the Supervisory Board."
This is an English translation of the Dutch press release. In the event of any disparity between the Dutch original and this translation, the Dutch text will prevail.
Note for editor, not for publication.
For further information, please contact Hugo van der Linde on 0031-10-8851200 or go to www.and.com


Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
CTOC Adds 3,000 Doctors, 500 Hospitals Ahead of Liquidity Push
Cathay Pacific Holds Firm on Flight Capacity Amid Middle East Conflict and Rising Fuel Costs
UPS and Teamsters Reach Agreement to Limit Driver Severance Program
Jefferies Upgrades Sodexo to Buy With €55 Target After Historic CEO Appointment
Luxury Car Sales in the Middle East Take a Hit Amid Iran War
MATCH Act Targets ASML and Chinese Chipmakers in New U.S. Export Crackdown
First Western Ship Transits Strait of Hormuz Since Iran War Began
Britain Courts Anthropic Amid US Defense Department Dispute
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
Elon Musk Ties SpaceX IPO Access to Mandatory Grok AI Subscriptions
UAE's Largest Natural Gas Facility Suspended After Attack-Triggered Fire
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
Private Credit Under Pressure: Is a Slow-Motion Crisis Unfolding?
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure 



